`By: Gary J. Speier
`Iain A. McIntyre
`Carlson, Caspers, Vandenburgh, Lindquist & Schuman
`225 South Sixth Street
`Suite 4200
`Minneapolis, MN 55402
`Tel.: 612-436-9600
`Fax: 612-436-9605
`Email: gspeier@carlsoncaspers.com
`Email: imcintyre@carlsoncaspers.com
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`———————————————
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`———————————————
`Teva Pharmaceuticals USA, Inc.,
`Petitioner,
`v.
`ASTRAZENECA AB,
`Patent Owner
`———————————————
`Inter Partes Review No.: Unassigned
`Patent No. RE44,186
`———————————————
`PETITIONER TEVA PHARMACEUTICALS USA INC.’S
`POWER OF ATTORNEY PURSUANT TO 37 C.F.R. §42.10(b)
`
`Submitted with
`PETITION FOR INTER PARTES REVIEW
`OF REISSUE PATENT NO. RE44186
`
`
`
`
`
`
`
`
`
`
`
`Scanned by CamScanner
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to §§42.6(e) and 42.105(a), I certify that I caused to be served a
`
`true and correct copy of the foregoing Power of Attorney by EXPRESS MAIL, on
`
`this 1st day of June, 2016, on counsel of record for AstraZeneca AB in IPR2015-
`
`10340 for Re44186 at its correspondence address as follows:
`
`Mr. Charles E. Lipsey
`Finnegan, Henderson, Farabow, Garrett and Dunner,
`11955 Freedom Drive
`Reston VA 20190
`
`
`
`
`
`Dated: __June 1, 2016_________
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Gary J. Speier/
`Gary J. Speier, Lead Counsel
`Reg. No. 45,458
`
`
`
`
`
`2